Pharmacogenetics and pharmacogenomics

Pharmacogenomic testing in community pharmacies to be considered as part of UK-wide review

A review of how pharmacogenomics can reduce harmful prescribing is due to be completed by 2025.…

Everything you need to know about the NHS genomic medicine service

A closer look at the progress made so far on NHS England’s new national genomic medicine service.…

Familial hypercholesterolaemia: identification and management

An overview of the symptoms, diagnostic criteria and role of genomics in the identification of familial hypercholesterolaemia and its management.…

DPYD genetic testing and the future of pharmacogenomic testing in routine care

Genetic testing can identify which drugs and doses are best for individual patients, personalising care and optimising outcomes.…

Whole-genome sequencing is ‘feasible’ for screening in primary care, research suggests

Presenting their findings, study authors said genomic sequencing in primary care could change the way patients and their families are managed by GPs.…

First routine clopidogrel genotype testing introduced at health board

NHS Tayside in Scotland has secured funding to genotype all new patients with an acute indication for clopidogrel in cardiology, stroke and vascular surgery.…

First pharmacogenomic testing service to be launched by pharmacy multiple later in 2022

Exclusive: If the Day Lewis service proves to be successful and cost effective, it could be commissioned more widely by the NHS.…

Pharmacogenomic testing: coming to a community pharmacy near you

In this episode of The PJ Pod, we investigate how community pharmacies around the world are providing pharmacogenomic testing directly to patients and explore how an NHS service might work in community pharmacies in the UK.…

Pharmacogenomics should be embedded into lifelong education and training, says RPS

The Royal Pharmaceutical Society says a strategy would address the need for pharmacy professionals to undertake the pharmacogenomics education needed after graduation.…

Cancer pharmacogenomics testing: are we hitting the mark?

The introduction of DPYD testing has launched the NHS into the world of pharmacogenomics, with huge benefits for patients. But with new data showing considerable variation in wait times for test results across England, we look at how this could be improved.…